Detalhe da pesquisa
1.
The Interdisciplinary Stem Cell Institute's Use of Food and Drug Administration-Expanded Access Guidelines to Provide Experimental Cell Therapy to Patients With Rare Serious Diseases.
Front Cell Dev Biol
; 9: 675738, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34169074
2.
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial.
Eur J Heart Fail
; 23(4): 661-674, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33811444
3.
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.
Oncotarget
; 7(11): 11899-912, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26933813